- Home
- TLSA vs CSBR Comparison
TLSA vs CSBR Comparison
Compare TLSA & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- CSBR
- Stock Information
- Founded
- TLSA 2013
- CSBR 1985
- Country
- TLSA United Kingdom
- CSBR United States
- Employees
- TLSA N/A
- CSBR N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TLSA Health Care
- CSBR Health Care
- Exchange
- TLSA Nasdaq
- CSBR Nasdaq
- Market Cap
- TLSA 87.8M
- CSBR 98.1M
- IPO Year
- TLSA 2000
- CSBR 1986
- Fundamental
- Price
- TLSA $0.74
- CSBR $9.78
- Analyst Decision
- TLSA
- CSBR Strong Buy
- Analyst Count
- TLSA 0
- CSBR 1
- Target Price
- TLSA N/A
- CSBR $8.00
- AVG Volume (30 Days)
- TLSA 442.0K
- CSBR 79.1K
- Earning Date
- TLSA 01-28-2025
- CSBR 03-11-2025
- Dividend Yield
- TLSA N/A
- CSBR N/A
- EPS Growth
- TLSA N/A
- CSBR N/A
- EPS
- TLSA N/A
- CSBR N/A
- Revenue
- TLSA N/A
- CSBR $53,571,000.00
- Revenue This Year
- TLSA N/A
- CSBR $14.19
- Revenue Next Year
- TLSA N/A
- CSBR $10.11
- P/E Ratio
- TLSA N/A
- CSBR N/A
- Revenue Growth
- TLSA N/A
- CSBR 7.19
- 52 Week Low
- TLSA $0.41
- CSBR $3.60
- 52 Week High
- TLSA $1.74
- CSBR $10.90
- Technical
- Relative Strength Index (RSI)
- TLSA 44.91
- CSBR 64.37
- Support Level
- TLSA $0.68
- CSBR $9.00
- Resistance Level
- TLSA $0.80
- CSBR $10.90
- Average True Range (ATR)
- TLSA 0.08
- CSBR 0.88
- MACD
- TLSA 0.01
- CSBR -0.05
- Stochastic Oscillator
- TLSA 34.34
- CSBR 66.67
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.